# A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure

Study · id `cardio:ct-nct03941691` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03941691](<https://clinicaltrials.gov/study/NCT03941691>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03941691

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 108 participants.

## Technical summary

Registry record NCT03941691. Randomized; no masking; primary purpose treatment. Start 2019-04-11 (actual); primary completion 2021-04-20 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 108 participants (planned count; ClinicalTrials.gov record NCT03941691, source copy `cardio:ctgov-nct03941691-2019-05-08`, retrieved 2026-10-26)
- Started: 2019-04-11 (actual) (ClinicalTrials.gov record NCT03941691, source copy `cardio:ctgov-nct03941691-2019-05-08`, retrieved 2026-10-26)
- Primary completion: 2021-04-20 (anticipated) (ClinicalTrials.gov record NCT03941691, source copy `cardio:ctgov-nct03941691-2019-05-08`, retrieved 2026-10-26)
- Completion: 2021-04-20 (anticipated) (ClinicalTrials.gov record NCT03941691, source copy `cardio:ctgov-nct03941691-2019-05-08`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03941691, source copy `cardio:ctgov-nct03941691-2019-05-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03941691-2019-05-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure
- Condition: Ventricular Septal Defect
- Intervention (Device): Fully Absorbable VSD Occlusion System
- Intervention (Device): VSD Occluder
- Lead sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
- Lead sponsor class: OTHER
- Collaborator: Shanghai Shape Memory Alloy Co., Ltd.
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry lists this organization as the lead sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital (`cardio:org-chinese-academy-of-medical-sciences-fuwai-hospital`)

## Provenance

Content hash: fa16e292b4ade47feec9916957c123b916fc8b76ba23acbb039cf53c68718d0b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
